ATNM
Actinium Pharmaceuticals Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$1.11
-0.02 ▼ -1.77%
🌙 3월 13일 6:20 PM ET (한국 3/14 07:20)
$1.13
+0.02 ▲ +1.80%
| Index | - | P/E | - | EPS (ttm) | -1.11 | Insider Own | 3.12% | Shs Outstand | 0.03B | Perf Week | -7.5% |
| Market Cap | 0.03B | Forward P/E | - | EPS next Y | 42.14% | Insider Trans | - | Shs Float | 0.03B | Perf Month | -0.89% |
| Enterprise Value | -0.02B | PEG | - | EPS next Q | -0.2 | Inst Own | 19.86% | Short Float | 3.53% | Perf Quarter | -21.83% |
| Income | -0.03B | P/S | 384.78 | EPS this Y | 26.05% | Inst Trans | 0.91% | Short Ratio | 8.22 | Perf Half Y | -33.93% |
| Sales | 0.00B | P/B | 2.51 | EPS next 5Y | 20.26% | ROA | -50.05% | Short Interest | 1.07M | Perf YTD | -18.38% |
| Book/sh | 0.44 | P/C | 0.65 | EPS past 3/5Y | -1.83% 21.99% | ROE | -133.09% | 52W High | -53.94% ($2.41) | Perf Year | -7.5% |
| Cash/sh | 1.71 | P/FCF | - | Sales past 3/5Y | - | ROIC | -241.66% | 52W Low | 8.82% ($1.02) | Perf 3Y | -87.56% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 20.65% | Gross Margin | -810% | Volatility(W/M) | 5.28% 6.77% | Perf 5Y | -87.91% |
| Dividend TTM | - | EV/Sales | -195.78 | Sales Y/Y TTM | 11.11% | Oper. Margin | -41486.67% | ATR (14) | 0.07 | Perf 10Y | -98.11% |
| Dividend Ex-Date | - | Quick Ratio | 7.96 | EPS Q/Q | 55.82% | Profit Margin | -38443.33% | RSI (14) | 43.03 | Recom | 1 |
| Dividend Gr. 3/5Y | - | Current Ratio | 7.96 | Sales Q/Q | - | SMA20 | -2.12% ($1.13) | Beta | -0.28 | Target Price | $5.75 |
| Payout | - | Debt/Eq | 0.08 | Earnings | 2026/03/13 | SMA50 | -9.03% ($1.22) | Rel Volume | 1.15 | Prev Close | $1.13 |
| Employees | 37 | LT Debt/Eq | 0.04 | EPS/Sales Surpr. | - | SMA200 | -24.55% ($1.47) | Avg Volume(3M) | 0.13M | Price | $1.11 |
| IPO | 2011/6/2 | Option/Short | Yes/Yes | Trades | 303 | Volume | 149,387 | Change | -1.77% |
뉴스 로딩 중...